Valion Bio Inc (VBIO) Peer Comparison
$1.18
$-0.01
(-0.84%)
As on 21-Oct-2026 11:28EDT
Market cap
$2 Mln
Revenue (TTM)
$2 Mln
P/E Ratio
--
P/B Ratio
0.5
Div. Yield
0 %
Edit
| Valion Bio Inc (VBIO) | Waystar Holding Corp. (WAY) | Life360, Inc. (LIF) | Westlin Corporation (WSTN) | Morningstar US Mid Cap PR USD (MMCP) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
2 | 5,246 | 3,346 | 81 | 10 |
Revenue ($ Mln) |
2 | 1,206 | 573 | -- | 4 |
Net Profit ($ Mln) |
-18.75 | 134.79 | 147.29 | 0.89 | -0.12 |
Net Margin (%) |
-1,003.19 | 11.18 | 25.72 | -- | 1.20 |
RoE (%) |
-130.74 | 3.43 | 25.36 | 4.09 | 54.17 |
Price to Earnings |
-- | 40.24 | 23.88 | 68.07 | -- |
Price-To-Book |
0.52 | 1.19 | 5.41 | -- | 1,802.81 |
Income Statement ($ Mln)
| Valion Bio Inc (VBIO) | Waystar Holding Corp. (WAY) | Life360, Inc. (LIF) | Westlin Corporation (WSTN) | Morningstar US Mid Cap PR USD (MMCP) | |
|---|---|---|---|---|---|
|
Operating Revenue
|
0.38 | 1,099.28 | 489.48 | -- | 2.05 |
|
Cost of Revenue
|
0.35 | 348.16 | 108.64 | -- | 1.39 |
|
Gross Profit
|
0.03 | 751.12 | 380.84 | -- | 0.66 |
|
Operating Expenses
|
7.90 | 501.81 | 362.02 | -- | 0.93 |
|
Operating Profit (EBIT)
|
-7.90 | 249.31 | 18.83 | -- | -0.27 |
|
Other Income
|
-- | -- | -- | -- | -- |
|
Profit before Tax
|
-7.99 | 171.76 | 32.66 | -0.01 | -0.28 |
|
Provision for Tax
|
-- | 59.67 | -118.17 | -- | -- |
|
Profit after Tax (Net Income)
|
-8.88 | 112.09 | 150.83 | -0.01 | -0.28 |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Consolidated Profit
|
-- | -- | -- | -- | -- |
Liabilities ($ Mln)
| Valion Bio Inc (VBIO) | Waystar Holding Corp. (WAY) | Life360, Inc. (LIF) | Westlin Corporation (WSTN) | Morningstar US Mid Cap PR USD (MMCP) | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
16.80 | 3,878.83 | 548.18 | 0.02 | -0.17 |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Non-Current Liabilities
|
14.16 | 1,688.21 | 314.72 | 0.00 | 0.37 |
|
Current Liabilities
|
0.65 | 218.06 | 96.79 | 0.18 | 0.51 |
|
Total Liabilities
|
31.61 | 5,785.10 | 959.69 | 0.20 | 0.71 |
Assets ($ Mln)
| Valion Bio Inc (VBIO) | Waystar Holding Corp. (WAY) | Life360, Inc. (LIF) | Westlin Corporation (WSTN) | Morningstar US Mid Cap PR USD (MMCP) | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
18.60 | 5,476.69 | 353.58 | 0.20 | 0.26 |
|
Current Assets
|
13.01 | 308.41 | 606.10 | 0.00 | 0.45 |
|
Total Assets
|
31.61 | 5,785.10 | 959.69 | -- | 0.71 |
|
Total Debt*
|
6.45 | 1,490.93 | 310.75 | -- | 0.35 |
|
Net Current Assets
|
12.36 | 90.35 | 509.31 | -- | -0.14 |
Cashflow ($ Mln)
| Valion Bio Inc (VBIO) | Waystar Holding Corp. (WAY) | Life360, Inc. (LIF) | Westlin Corporation (WSTN) | Morningstar US Mid Cap PR USD (MMCP) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-7.00 | 309.67 | 88.63 | -- | -0.21 |
|
Cash Flow from Investing Activities
|
-0.71 | -680.90 | -35.33 | -- | -- |
|
Cash from Financing Activities
|
18.35 | 243.45 | 282.07 | -- | 0.16 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| Valion Bio Inc (VBIO) | Waystar Holding Corp. (WAY) | Life360, Inc. (LIF) | Westlin Corporation (WSTN) | Morningstar US Mid Cap PR USD (MMCP) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
-68.86 | 2.31 | 24.76 | -- | -2,636.14 |
|
ROE (%)
|
-91.85 | 3.22 | 33.27 | -- | 170.10 |
|
ROA (%)
|
-51.60 | 2.16 | 21.53 | -- | -39.73 |
|
EBIT Margin (%)
|
-- | -- | -- | -- | -- |
|
Net Margin (%)
|
-2,324.08 | 10.20 | 30.81 | -- | -13.81 |
|
Cash Profit Margin (%)
|
-- | -- | -- | -- | -- |
Growth Ratios
| Valion Bio Inc (VBIO) | Waystar Holding Corp. (WAY) | Life360, Inc. (LIF) | Westlin Corporation (WSTN) | Morningstar US Mid Cap PR USD (MMCP) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-1.00 | 0.17 | 0.32 | -- | 0.00 |
|
EBIT Growth (%)
|
-- | -- | -- | -- | -- |
|
Net Profit Growth (%)
|
-56.99 | 686.09 | 3,411.35 | -- | 0.00 |
|
EPS Growth (%)
|
-2.94 | 6.32 | 33.35 | -- | -- |
|
Book Value Growth (%)
|
-- | -- | -- | -- | -- |
Valuation Ratios
| Valion Bio Inc (VBIO) | Waystar Holding Corp. (WAY) | Life360, Inc. (LIF) | Westlin Corporation (WSTN) | Morningstar US Mid Cap PR USD (MMCP) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
-0.04 | 57.66 | 36.22 | -- | -- |
|
Price / Book Value
|
0.02 | 1.67 | 9.97 | -- | -- |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
0.75 | 20.18 | 113.94 | -- | -- |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| Valion Bio Inc (VBIO) | Waystar Holding Corp. (WAY) | Life360, Inc. (LIF) | Westlin Corporation (WSTN) | Morningstar US Mid Cap PR USD (MMCP) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.38 | 0.38 | 0.57 | -- | -2.13 |
|
Short term debt to equity ratio
|
0.03 | 0.01 | 0.00 | -- | -0.75 |
|
Current Ratio
|
20.13 | 1.41 | 6.26 | 0.00 | 0.88 |
|
Quick Ratio
|
8.53 | -- | 6.16 | -- | -- |
|
Interest Coverage
|
-53.75 | 3.22 | -- | -- | -31.30 |
Operating Efficiency Ratios
| Valion Bio Inc (VBIO) | Waystar Holding Corp. (WAY) | Life360, Inc. (LIF) | Westlin Corporation (WSTN) | Morningstar US Mid Cap PR USD (MMCP) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
0.26 | 16.69 | 16.94 | -- | -- |
|
Asset Turnover
|
0.02 | 0.21 | 0.70 | -- | 2.88 |
|
Receivable days
|
33.47 | 55.08 | 53.89 | -- | -- |
|
Inventory Days
|
332.90 | -15.38 | 30.13 | -- | -- |
|
Payable days
|
202.97 | 51.57 | 23.32 | -- | 80.44 |
|
Cash Conversion Cycle
|
163.39 | -14.70 | 60.70 | -- | -- |
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
